Comparison of Direct Oral Anticoagulants for Treatment of Cerebral Venous Thrombosis – A Retrospective Cohort Study
Limited available evidence comparing DOACs with warfarin suggests efficacy and safety of DOACs for CVT. We aimed to evaluate whether a specific DOAC is preferred for the treatment of CVT. This retrospective cohort study included adult patients with CVTs between September 2018 and September 2022 trea...
Saved in:
Main Authors: | Paul Phan PharmD, Lisa T. Hong PharmD, BCPS, APh, PNAP |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296251316869 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01) -
Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?
by: Nikhil Vojjala, et al.
Published: (2025-01-01) -
Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism
in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01) -
Evaluation of Rivaroxaban Exposure via
Anti-Xa Levels During VTE Prophylaxis
in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01) -
Tenecteplase vs Reteplase in Patients with Acute ST-Elevation Myocardial Infarction: A Retrospective Cohort Study
by: Adham Mohamed PharmD, et al.
Published: (2025-02-01)